454 related articles for article (PubMed ID: 17313565)
1. Management of idiopathic thrombocytopenic purpura in elderly patients.
Andrès E; Daou S; Zimmer J; Federici L; Maloisel F
Eur J Haematol; 2007 Feb; 78(2):175. PubMed ID: 17313565
[No Abstract] [Full Text] [Related]
2. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.
Fabrizio F; Luzzatto G; Ramon R; Randi ML; De Silvestro G; Girolami A
Haematologica; 2000 Aug; 85(8):888-90. PubMed ID: 10942951
[No Abstract] [Full Text] [Related]
4. [Idiopathic thrombocytopenic purpura: therapeutic aspects in the adult].
Canevari A; Pagnucco G; Castelli G; Livraghi A; Santagostino A; Bernasconi C
Haematologica; 1991 Jun; 76 Suppl 3():124-30. PubMed ID: 1752509
[No Abstract] [Full Text] [Related]
5. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
7. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
[TBL] [Abstract][Full Text] [Related]
8. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
[TBL] [Abstract][Full Text] [Related]
9. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC
J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
[TBL] [Abstract][Full Text] [Related]
10. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy in ITP: we keep removing a healthy functional organ.
Anguita E; Candel FJ; González-Del Castillo J; Martín-Sánchez FJ
Ann Hematol; 2016 Oct; 95(11):1911-2. PubMed ID: 27577110
[No Abstract] [Full Text] [Related]
12. [Thrombocytopenia: therapeutic aspects in the child].
Mori PG
Haematologica; 1991 Jun; 76 Suppl 3():131-7. PubMed ID: 1752510
[No Abstract] [Full Text] [Related]
13. [Splenectomy in immune thrombocytopenia and other hematological diseases].
Lanzi S; Lancini GP; Piardi T; Biasca F; Ottaviani GM; Rossi G; Pizzoccaro C; Pouchè A
G Chir; 1999; 20(11-12):479-86. PubMed ID: 10645065
[TBL] [Abstract][Full Text] [Related]
14. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
Litton G
Am J Hematol; 2008 Apr; 83(4):344. PubMed ID: 18186526
[No Abstract] [Full Text] [Related]
15. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
Sikorska A; Konopka L; Maślanka K
Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic immune thrombocytopenic purpura in children and adults.
Blanchette V; Freedman J; Garvey B
Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
[TBL] [Abstract][Full Text] [Related]
17. Re: Recurrent immune thrombocytopenic purpura in children.
Roganovic J; Letica-Crepulja M; Dordevic L
Pediatr Hematol Oncol; 2008; 25(3):243-4. PubMed ID: 18432509
[No Abstract] [Full Text] [Related]
18. Acute idiopathic thrombocytopenic purpura--management in childhood.
Bolton-Maggs PH
Blood; 1997 Feb; 89(4):1465; author reply 1466. PubMed ID: 9028974
[No Abstract] [Full Text] [Related]
19. Recurrent immune thrombocytopenic purpura in children.
Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
[TBL] [Abstract][Full Text] [Related]
20. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy.
Kondo H; Iseki T; Goto S; Takaso T; Ohto M; Okuda K
Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
